Breaking News, Promotions & Moves

Bio X Cell Appoints Christopher Conway CEO

Conway most recently served as President of R&D at Curia and brings extensive experience in small molecule and biologics drug discovery.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bio X Cell, LLC, a producer of monoclonal antibodies for preclinical in vivo research, has appointed Christopher Conway as Chief Executive Officer.   Mr. Conway most recently served as President of R&D at Curia and brings extensive experience in both small molecule and biologics drug discovery. Chris joined Curia (formerly AMRI) in 2008 from Johnson & Johnson and held a series of commercial leadership roles. In 2015 he was promoted to Senior Vice President and Drug Discovery and Develo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters